{"title":"Human brain organoids for understanding substance use disorders.","authors":"Kangle Li, Longjun Gu, Hongwei Cai, Hui-Chen Lu, Ken Mackie, Feng Guo","doi":"10.1016/j.dmpk.2024.101036","DOIUrl":null,"url":null,"abstract":"<p><p>Substance use disorders (SUDs) are complex mental health conditions involving a problematic pattern of substance use. Challenges remain in understanding its neural mechanisms, which are likely to lead to improved SUD treatments. Human brain organoids, brain-like 3D in vitro cultures derived from human stem cells, show unique potential in recapitulating the response of a developing human brain to substances. Here, we review the recent progress in understanding SUD using human brain organoid models focusing on neurodevelopmental perspectives. We first summarize the background of SUD in humans. Moreover, we introduce the development of various human brain organoid models and then discuss current progress and findings underlying the abuse of substances like nicotine, alcohol, and other addictive drugs using organoid models. Furthermore, we review efforts to develop organ chips and microphysiological systems to engineer better human brain organoids for advancing SUD studies. Lastly, we conclude by elaborating on the current challenges and future directions of SUD studies using human brain organoids.</p>","PeriodicalId":11298,"journal":{"name":"Drug Metabolism and Pharmacokinetics","volume":" ","pages":"101036"},"PeriodicalIF":2.7000,"publicationDate":"2024-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug Metabolism and Pharmacokinetics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.dmpk.2024.101036","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
Substance use disorders (SUDs) are complex mental health conditions involving a problematic pattern of substance use. Challenges remain in understanding its neural mechanisms, which are likely to lead to improved SUD treatments. Human brain organoids, brain-like 3D in vitro cultures derived from human stem cells, show unique potential in recapitulating the response of a developing human brain to substances. Here, we review the recent progress in understanding SUD using human brain organoid models focusing on neurodevelopmental perspectives. We first summarize the background of SUD in humans. Moreover, we introduce the development of various human brain organoid models and then discuss current progress and findings underlying the abuse of substances like nicotine, alcohol, and other addictive drugs using organoid models. Furthermore, we review efforts to develop organ chips and microphysiological systems to engineer better human brain organoids for advancing SUD studies. Lastly, we conclude by elaborating on the current challenges and future directions of SUD studies using human brain organoids.
物质使用障碍(SUD)是一种复杂的精神疾病,涉及有问题的物质使用模式。在了解其神经机制方面仍存在挑战,而了解这些机制很可能有助于改进药物使用障碍的治疗。人脑器官组织是由人类干细胞衍生的类脑三维体外培养物,在重现发育中的人脑对药物的反应方面显示出独特的潜力。在此,我们从神经发育的角度回顾了利用人脑类器官模型了解 SUD 的最新进展。我们首先总结了人类 SUD 的背景。此外,我们还介绍了各种人脑类器官模型的发展,然后讨论了目前利用类器官模型研究尼古丁、酒精和其他成瘾药物滥用的进展和发现。此外,我们还回顾了开发器官芯片和微生理系统的工作,以设计出更好的人脑类器官,推动 SUD 研究。最后,我们阐述了使用人脑器官模型进行 SUD 研究的当前挑战和未来方向。
期刊介绍:
DMPK publishes original and innovative scientific papers that address topics broadly related to xenobiotics. The term xenobiotic includes medicinal as well as environmental and agricultural chemicals and macromolecules. The journal is organized into sections as follows:
- Drug metabolism / Biotransformation
- Pharmacokinetics and pharmacodynamics
- Toxicokinetics and toxicodynamics
- Drug-drug interaction / Drug-food interaction
- Mechanism of drug absorption and disposition (including transporter)
- Drug delivery system
- Clinical pharmacy and pharmacology
- Analytical method
- Factors affecting drug metabolism and transport
- Expression of genes for drug-metabolizing enzymes and transporters
- Pharmacogenetics and pharmacogenomics
- Pharmacoepidemiology.